Key result
Continuous glucose monitoring usage was high (77.8%) among patients with type 1 diabetes, but glycaemic control remained suboptimal (8.51%) with low adherence to retinal (43.8%) and foot (28.4%) screenings.
Observational (n=175)
No
Despite high continuous glucose monitoring adoption in regional Australia, significant gaps exist in essential diabetes care processes and glycaemic control remains suboptimal.
BACKGROUND AND AIMS: Real-world adherence to guideline-recommended diabetes care in regional Australia is poorly described. This study aimed to evaluate adherence to diabetes care processes, comorbidity burden and continuous glucose monitoring (CGM) metrics among individuals with type 1 diabetes (T1D) attending a regional hospital in Central Queensland, Australia. RESEARCH DESIGN AND METHODS: A retrospective audit of 175 patients with T1D was conducted using electronic medical records. Data on demographics, care process adherence, comorbidities and CGM metrics were analysed. A gradient boosting machine (GBM) model assessed factors influencing glycaemic control. RESULTS: was 8.51%, indicating suboptimal glycaemic control. Adherence to screening protocols varied: blood pressure monitoring (79.8%), lipid profile screening (68.8%), kidney function assessment (89.7%), retinopathy screening (43.8%) and foot examinations (28.4%). CGM usage was high (77.8%), with an average of 14 scans per day. CGM metrics showed a mean time in range of 42.9%, time above range of 54.2% and a glucose management indicator of 7.99%. The GBM model identified body mass index as the strongest modifiable factor influencing glycaemic control. CONCLUSIONS: Despite high CGM adoption, glycaemic control remains suboptimal and significant gaps exist in essential care processes, particularly retinal and foot screenings. These findings highlight the need for targeted interventions to improve diabetes management in regional Australian settings.
No takes yet. Share an insight, caveat, or question.
Syed et al. (2025) conducted an observational in Type 1 diabetes (n=175). Continuous glucose monitoring and diabetes care processes was evaluated on Adherence to diabetes care processes, comorbidity burden and continuous glucose monitoring metrics. Continuous glucose monitoring usage was high (77.8%) among patients with type 1 diabetes, but glycaemic control remained suboptimal (8.51%) with low adherence to retinal (43.8%) and foot (28.4%) screenings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: